Live Breaking News & Updates on Kiora Pharmaceuticals Daily
Stay updated with breaking news from Kiora pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX – Get Free Report) saw a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 66,500 shares, a decrease of 50.7% from the April 30th total of 135,000 shares. Based on an average daily trading volume, of 215,600 shares, the short-interest […] ....
Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX – Get Free Report) shares were down 3.8% during mid-day trading on Thursday . The stock traded as low as $0.58 and last traded at $0.58. Approximately 78,144 shares were traded during trading, a decline of 96% from the average daily volume of 1,794,033 shares. The stock had previously closed at […] ....
Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX – Get Free Report) dropped 3.8% during mid-day trading on Thursday . The company traded as low as $0.58 and last traded at $0.58. Approximately 78,144 shares changed hands during trading, a decline of 96% from the average daily volume of 1,794,033 shares. The stock had previously closed at $0.61. Kiora […] ....
Kiora Pharmaceuticals (NASDAQ:KPRX – Get Free Report) and Vaxxinity (NASDAQ:VAXX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, institutional ownership, risk, dividends and earnings. Volatility & Risk Kiora Pharmaceuticals has a beta […] ....
HC Wainwright reiterated their buy rating on shares of Kiora Pharmaceuticals (NASDAQ:KPRX – Free Report) in a research note issued to investors on Monday, Benzinga reports. HC Wainwright also issued estimates for Kiora Pharmaceuticals’ Q4 2023 earnings at ($0.33) EPS, FY2023 earnings at ($2.66) EPS, Q1 2024 earnings at ($0.24) EPS, Q2 2024 earnings at […] ....